KU Leuven-ko ikertzaileekin lankidetzan egindako argitalpenak (5)

2011

  1. EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells

    British Journal of Haematology, Vol. 154, Núm. 3, pp. 337-348

2008

  1. In vitro validation of γ-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia

    Haematologica, Vol. 93, Núm. 4, pp. 533-542

2007

  1. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia

    Nature Genetics, Vol. 39, Núm. 5, pp. 593-595

2005

  1. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32)

    Blood, Vol. 105, Núm. 12, pp. 4849-4852

2002

  1. Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5; 12)(q31;p13)

    Blood, Vol. 99, Núm. 5, pp. 1776-1784